Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cancer risk in type 2 diabetes.

× No keyword cloud information.

31 in total

1. On the origin of cancer cells.

Authors: O WARBURG
Journal: Science Date: 1956-02-24 Impact factor: 47.728

2. Effect of gliclazide on DNA damage in human peripheral blood lymphocytes and insulinoma mouse cells.

Authors: A Sliwinska; J Blasiak; J Drzewoski
Journal: Chem Biol Interact Date: 2006-07-27 Impact factor: 5.192

Review 3. Physical activity and gynecologic cancer prevention.

Authors: Anne E Cust
Journal: Recent Results Cancer Res Date: 2011

4. Use of sulphonylurea and cancer in type 2 diabetes-The Hong Kong Diabetes Registry.

Authors: Xilin Yang; Wing Yee So; Ronald C W Ma; Linda W Y Yu; Gary T C Ko; Alice P S Kong; Vanessa W S Ng; Andrea O Y Luk; Risa Ozaki; Peter C Y Tong; Chun-Chung Chow; Juliana C N Chan
Journal: Diabetes Res Clin Pract Date: 2010-12 Impact factor: 5.602

5. Low triglyceride and nonuse of statins is associated with cancer in type 2 diabetes mellitus: the Hong Kong Diabetes Registry.

Authors: Xilin Yang; Ronald C W Ma; Wing Yee So; Linda W L Yu; Alice P S Kong; Gary T C Ko; Gang Xu; Risa Ozaki; Peter C Y Tong; Juliana C N Chan
Journal: Cancer Date: 2010-10-11 Impact factor: 6.860

Review 6. From hyperglycemia to diabetic kidney disease: the role of metabolic, hemodynamic, intracellular factors and growth factors/cytokines.

Authors: Bieke F Schrijvers; An S De Vriese; Allan Flyvbjerg
Journal: Endocr Rev Date: 2004-12 Impact factor: 19.871

7. Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin.

Authors: Samantha L Bowker; Sumit R Majumdar; Paul Veugelers; Jeffrey A Johnson
Journal: Diabetes Care Date: 2006-02 Impact factor: 19.112

8. Risk factors in V-shaped risk associations with all-cause mortality in type 2 diabetes-The Hong Kong Diabetes Registry.

Authors: Wing Yee So; Xilin Yang; Ronald C W Ma; Alice P S Kong; Christopher W K Lam; Chung Shun Ho; Clive S Cockram; Gary T C Ko; Chun-Chung Chow; Vivian Wong; Peter C Y Tong; Juliana C N Chan
Journal: Diabetes Metab Res Rev Date: 2008 Mar-Apr Impact factor: 4.876

Review 9. Obesity related hyperinsulinaemia and hyperglycaemia and cancer development.

Authors: Susen Becker; Laure Dossus; Rudolf Kaaks
Journal: Arch Physiol Biochem Date: 2009-05 Impact factor: 4.076

10. Similar risk of malignancy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: findings from a 5 year randomised, open-label study.

Authors: J Rosenstock; V Fonseca; J B McGill; M Riddle; J P Hallé; I Hramiak; P Johnston; M Davis
Journal: Diabetologia Date: 2009-07-16 Impact factor: 10.122

2 in total

Review 1. Hypoglycemia and Comorbidities in Type 2 Diabetes.

Authors: Alice P S Kong; Juliana C N Chan
Journal: Curr Diab Rep Date: 2015-10 Impact factor: 4.810

2. Additive effects of blood glucose lowering drugs, statins and renin-angiotensin system blockers on all-site cancer risk in patients with type 2 diabetes.

Authors: Alice P S Kong; Xilin Yang; Wing-Yee So; Andrea Luk; Ronald C W Ma; Risa Ozaki; Kitty K T Cheung; Heung-Man Lee; Linda Yu; Gang Xu; Chun-Chung Chow; Juliana C N Chan
Journal: BMC Med Date: 2014-05-13 Impact factor: 8.775

2 in total